Literature DB >> 11044646

The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT).

K Münstedt1, A Entezami, A Wartenberg, U Kullmer.   

Abstract

Physicians represent the main providers of unconventional cancer therapies (UCT) in Germany. However, little is known about providers' characteristics, as well as their attitudes towards UCT. 833 questionnaires on this topic answered by general practitioners and hospital physicians were analysed. Providers differed significantly from non-providers with respect to gender (male>female, i.e. more male providers), age (older>younger), amount of subjective knowledge about UCT, place of work (office>hospital>university clinic), greater wish for coverage of UCT costs, the belief in future positive trends concerning UCT, the recognition of patients' demand for UCT, the number of patients seen per month and medical specialty (GPs>oncologists and radiation oncologists). UCT were not considered to be highly effective, but estimations varied considerably. Further investigations in this area, better education about UCT, training in coping strategies with the fate of cancer patients, and reasonable complementary treatments appear to be of the utmost importance.

Entities:  

Mesh:

Year:  2000        PMID: 11044646     DOI: 10.1016/s0959-8049(00)00194-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  13 in total

1.  Alternative and complementary medicine of psychiatric disorders.

Authors:  Jürgen Fritze
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12       Impact factor: 5.270

2.  Complementary and Alternative Medicine in Palliative Care: A Comparison of Data From Surveys Among Patients and Professionals.

Authors:  Ralph Muecke; Magdalena Paul; Christina Conrad; Christoph Stoll; Karsten Muenstedt; Oliver Micke; Franz J Prott; Jens Buentzel; Jutta Huebner
Journal:  Integr Cancer Ther       Date:  2015-07-26       Impact factor: 3.279

3.  How oncologists discuss complementary therapy use with their patients: an audio-tape audit.

Authors:  Penelope E Schofield; Ilona Juraskova; Phyllis N Butow
Journal:  Support Care Cancer       Date:  2003-04-24       Impact factor: 3.603

4.  Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey.

Authors:  G Nagel; H Hoyer; D Katenkamp
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

5.  Trick or treat? Australian newspaper portrayal of complementary and alternative medicine for the treatment of cancer.

Authors:  Reegan Mercurio; Jaklin Ardath Eliott
Journal:  Support Care Cancer       Date:  2009-11-27       Impact factor: 3.603

6.  Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway.

Authors:  A Kolstad; T Risberg; Y Bremnes; T Wilsgaard; H Holte; O Klepp; O Mella; E Wist
Journal:  Support Care Cancer       Date:  2004-02-06       Impact factor: 3.603

7.  Complementary therapy use by cancer patients. Physicians' perceptions, attitudes, and ideas.

Authors:  Maeve O'Beirne; Marja Verhoef; Elan Paluck; Carol Herbert
Journal:  Can Fam Physician       Date:  2004-06       Impact factor: 3.275

Review 8.  A Review of Integrative Medicine in Gynaecological Oncology.

Authors:  M Kalder; T Müller; D Fischer; A Müller; W Bader; M W Beckmann; C Brucker; C C Hack; V Hanf; A Hasenburg; A Hein; S Jud; M Kiechle; E Klein; D Paepke; A Rotmann; F Schütz; G Dobos; P Voiß; S Kümmel
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

9.  Attitudes of members of the German Society for Palliative Medicine toward complementary and alternative medicine for cancer patients.

Authors:  A C Conrad; K Muenstedt; O Micke; F J Prott; R Muecke; J Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-06       Impact factor: 4.553

10.  Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.

Authors:  Guo-Shiou Liao; Maria Karmella Apaya; Lie-Fen Shyur
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.